Cancer
Care Teleconference about mesothelioma was held July 31.
Listen to the recorded discussion.
Presenter was Richard Gralla, M.D., Professor of Medicine and medical
oncologist at Columbia University, New York, NY.
Drug Helps Treat Asbestos-Related Lung Cancer
An experimental drug is the first treatment shown to be effective against
a form of lung cancer that is related to asbestos exposure, researchers
report. The cancer, called mesothelioma, causes severe, throbbing chest
pain--"the really devastating aspect of this disease that just
haunts people"--and doctors have had no way to treat it, said study
author Dr. Nicholas Vogelzang, director of the University of Chicago
Cancer Research Center.
Patients generally live about 6 to 9 months after diagnosis. But the
new drug, Alimta (pemetrexed), was shown to add an average of 3 months
to patients' lives, Vogelzang said here Monday at a meeting of the American
Society of Clinical Oncology (ASCO). "We now have a treatment that
not only treats this disease but also improves symptoms," he said.
"This is the first time we've ever documented an improvement in
mesothelioma survival." Other experts also were enthusiastic.